Related content

Effect of Imatinib Mesylate in a Patient with a Metastatic Gastrointestinal Stromal Tumor with a c-kit Mutation in Exon 11

By Kubota Keisuke   Katayama Atom   Takeshita Yutarou   Nozaki Koji   Ueda Tetsuya   Imamura Kazuhiro   Hiki Naoki   Nomura Sachiyo   Kaminishi Michio   Mafune Ken-Ichi  

Digestive Diseases and Sciences, Vol. 52, Iss. 7, 2007-07 ,pp. : 1725-1729

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Follow-Up Outcome of Imatinib Mesylate Treatment for Recurrent and Unresectable Gastrointestinal Stromal Tumors

By  

Digestion, Vol. 87, Iss. 1, 2013-01 ,pp. : 47-52

Karger

Access to resources Recommend Favorite

Prevalence of Non-Organ-Specific Autoantibodies in Patients Suffering from Duodenal Ulcer With and Without Helicobacter pylori Infection

By Pellicano Rinaldo   Touscoz Giovanni Antonio   Smedile Antonina   Berrutti Mara   Saracco Giorgio   Repici Alessandro   Ponzetto Antonio   Rizzetto Mario  

Digestive Diseases and Sciences, Vol. 49, Iss. 3, 2004-03 ,pp. : 395-398

Springer Publishing Company

Access to resources Recommend Favorite

Imatinib Mesylate (Gleevec) Hepatotoxicity

By Mindikoglu Ayse   Regev Arie   Bejarano Pablo   Martinez Enrique   Jeffers Lennox   Schiff Eugene  

Digestive Diseases and Sciences, Vol. 52, Iss. 2, 2007-02 ,pp. : 598-601

Springer Publishing Company

Access to resources Recommend Favorite

Expression and functional analysis of menin in a multiple endocrine neoplasia type 1 (MEN1) patient with somatic loss of heterozygosity in chromosome 11q13 and unidentified germline mutation of the MEN1 gene

By Naito Junko   Kaji Hiroshi   Sowa Hideaki   Kitazawa Riko   Kitazawa Sohei   Tsukada Toshihiko   Hendy Geoffrey   Sugimoto Toshitsugu   Chihara Kazuo  

Endocrine Journal, Vol. 29, Iss. 3, 2006-06 ,pp. : 485-490

Humana Press, Inc

Access to resources Recommend Favorite